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Abstract
Background: Fragile X Syndrome is the most common known genetic cause of autism. The Fmr1-KO mouse,
lacks the fragile X mental retardation protein (FMRP), and is used as a model of the syndrome. The core
behavioral deficits of autism may be conceptualized either as excessive adherence to patterns as seen in
repetitive actions and aberrant language, or as insensitivity to subtle but socially important changes in patterns.
The hippocampus receives information from the entorhinal cortex and plays a crucial role in the processing of
patterned information. To gain more insight into the physiological function of FMRP and the neuronal
mechanisms underlying fragile X syndrome, we examined the electrophysiological response of the hippocampus
to pair pulse stimulation as a measure of patterned information processing and how it is affected in the Fmr1KO mouse.
Methods: In this study, we used paired-pulse stimulation of the afferent perforant path and recorded from the
CA1 region of the hippocampus. Two-month-old FVB/NJ male mice and age-matched Fmr1-KO mice were used in
this study. Hippocampal slices were prepared, equilibrated in artificial cerebrospinal fluid (aCSF), and excitatory post
synaptic potentials (EPSPs) measured by stimulating the perforant path of the dentate gyrus (DG) while recording
from the molecular layer of CA1. Stimulation occurred by setting current and pulse width to evoke a fixed
percentage of maximal EPSP amplitude. This stimulation paradigm allowed us to examine the processing
capabilities of the hippocampus as a function of increasing interstimulus intervals (ISI) and how taurine, a GABAA
receptor agonist, affects such information processing.
Results: We found that hippocampal slices from wild type (WT) showed pair-pulse facilitation at ISI of 100-300 ms
whereas slices from Fmr1-KO brains showed a consistent pair-pulse depression at a comparable ISI. Addition of
10 μM taurine to WT slices resulted in a drastic decrease of the peak response to the second stimulus, resulting in
an initial depression at 100 ms ISI followed by potentiation at higher ISI (150 ms and above). In the presence of
taurine, the amplitude of the second response remained significantly lower than in its absence. Fmr1-KO mice
however, were completely insensitive to taurine application and pair-pulse stimulation always resulted in a
depression of the response to the second stimulus.
Conclusions: Previously we reported that Fmr1-KO mice have reduced beta subunits of the GABAA receptors. We
also showed as well as others that taurine acts as an agonist or a modulator for GABAA receptors. Therefore, the
insensitivity of Fmr1-KO slices to taurine application could be due to the reduced binding sites on the GABAA
receptors in the Fmr1-KO mice.
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Background
Fragile X is a common mental retardation syndrome
that results from the silencing of a single gene, FMR1,
on the X chromosome [1,2]. The loss of the FMR1 gene
product, FMRP, leads to mental retardation in males
and to a range of deficits in heterozygous females. The
syndrome has an autistic-like behavioral profile with
hyper-arousal, self-stimulation, tactile-defensiveness and
hypersensitivity to sensory stimuli [1,3]. There is also an
increased prevalence of childhood seizures [4,5]. Physical
features of the syndrome usually include enlarged testicles and prominent ears [4]. Neuroanatomical features
include abnormal dendritic spine morphology [6-8], as
well as alterations in the volume of the lateral ventricles
and other structures [5,9]. FMRP is an RNA binding
protein [10] that may act at the level of mRNA translation or translocation [11,12].
The fragile X mouse model for this disorder was generated by insertional mutagenesis of the mouse Fmr1
gene that eliminated expression of the mouse protein,
Fmrp [3]. The fragile X mouse exhibits features that
resemble elements of the fragile X syndrome. These
include enlarged testicles, mildly impaired learning
behavior [3,13], an increased susceptibility to audiogenic
seizures [14,15], altered behaviors associated with anxiety [16] and abnormal dendritic spine morphology
[17-19]. The increase in susceptibility to seizures and
spine dysgenesis may be due to the role of Fmrp as an
activity-dependent regulator of translation [11,20,21].
Increased seizure susceptibility may be related to
increased group 1 metabotropic receptor (mGluR)
response [22] and to reduced GABAA receptor expression [23]. In addition, long term depression (LTD) is
enhanced in the fragile X mouse [24] and it has been
proposed that this increase as well as spine dysgenesis
are related to malfunction of a signaling cascade
initiated by group 1 mGluRs in which Fmrp regulates
translation of specific mRNAs [25].
Absence of Fmrp in the mouse model has also been
shown to increase cerebellar LTD and to attenuate eye
blink conditioning [26]. Analysis of the anterior piriform
cortex showed reduced long term potentiation (LTP) in
older animals [27]. No changes in paired pulse facilitation in hippocampal circuits have been noted when the
interpulse interval was 40 ms [28] or 50 to 1600 ms
[27]. However, these studies have examined the monosynaptic connections between the Schaffer collaterals and
their postsynaptic target, the CA1 pyramidal cells. Here
we have examined the integrative properties of the
whole hippocampal formation and studied short-term
plasticity within this structure and how it is affected by
taurine.
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Methods
Animals: All mice used in this study were two-monthold FVB/NJ males. Mice were housed in groups of three
in a pathogen-free room, maintained on a 12 hr light/
dark cycle and given food and water ad libitum. All procedures were approved by the Institutional Animal Care
and Use Committee of the College of Staten Island/
CUNY, and were in conformity with the National Institutes of Health Guidelines. The number of mice sufficient to provide statistically reliable results was used in
these studies.
Slice preparation: Hippocampal slices (400 µm) were
prepared using an automated Leica tissue chopper. Artificial cerebrospinal fluid (aCSF) consisted of the following composition (mM): NaCl 124, KCl 3, CaCl 2 2.4,
MgSO4 1.3, NaH2PO4 1.25, NaHCO3 26, and glucose 10
(gassed with 95% O2 / 5% CO2, pH = 7.4). Slices were
prepared on ice-cold aCSF and calibrated for 45min at
room temperature (RT) in oxygenated aCSF prior to
recording.
Recording and stimulation: Extracellular recordings of
evoked excitatory postsynaptic potentials (EPSPs) were
measured by placing the stimulating bipolar platinum
electrodes in perforant path close to the suprapyamidal
blade of the DG in the outer third of the molecular
layer. Recording electrodes (tip impedance 1-5 MΩ)
were placed in the middle or outer region of the molecular layer of CA1 to record EPSPs. This stimulation
paradigm allowed us to assess both the evoked
responses and the overall integrative properties of the
whole hippocampus. Stimulation parameters for test
pulses (0.05 Hz) were standardized across slices by setting current and pulse width to evoke a fixed percentage
of maximal EPSP amplitude in any given data set. Similarly, stimulus intensity for plasticity induction was standardized for all data sets. The stimulus current that
produced about 40% of maximal responses (usually
100– 150 μA) was used throughout the experiment for
monitoring test pulses. Data were sampled and digitized
at 100 kHz with a band-pass filtered between 0.3 Hz
and 3 kHz.
Statistical analysis: Statistical significance was determined by Student’s t-test. Each value was expressed as
the mean ± SEM. Differences were considered statistically significant when the calculated p value was less
than 0.05.
Results
Altered short term plasticity in the hippocampus of
fragile X mice

In the WT hippocampal slices, paired pulse stimulation
at inter-stimulus intervals (ISI) of 100 ms and up to
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300 ms consistently yielded facilitation as determined by
the ratio of the evoked response to the second stimulus
(p2) compared to the first stimulus (p1). On the other
hand, stimulation of hippocampal slices from Fmr1-KO
resulted in a consistent depression of the second evoked
response at all ISI used (Figure 1). Although many factors could contribute to the observed electrophysiological differences between the WT and Fmr1-KO,
alterations in the GABAergic system could be a contributing factor to these alterations in short term plasticity
observed in the Fmr1-KO hippocampus. Consistent with
this, bath application of taurine (10µM), a GABA A
receptor agonist, resulted in a paired pulse depression of
WT responses but not Fmr1-KO (Figure 1).

Discussion
We have previously shown that GABA A receptor
expression is down-regulated [23] and cortical GABAergic interneurons are less abundant in Fmr1-KO mice
[29,30], suggesting reduced GABA signaling in these
mice.
To assess electrophysiologically the functional significance of reduced expression of the GABA A and the
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alterations of the inhibitory system in the Fmr1-KO hippocampus, we performed electrophysiological recording
from the CA1 region of the hippocampus after paired
pulse stimulation of the perforant path. This allowed us
to determine the overall integrative properties of neuronal circuits within the hippocampal formation.
The finding that Fmr1-KO mice have altered paired
pulse facilitation indicates that the mechanism underlying short-term plasticity in the hippocampus is compromised (Figure 1). Several factors could be at the origin
of these alterations. We have shown that the GABAergic
inhibitory system is altered in these mice [23]. Additionally, we showed that the expression of somatostatin is
down-regulated in Fmr1-KO mice [30]. Furthermore we
showed that the reduced expression of this neuropeptide
is consistent with both central and peripheral features of
the fragile X syndrome.
There are several studies indicating the interaction of
taurine with GABAA and glycine receptors acting as a
modulator [31-36] or an agonist [37-44]. In heterologously expressed GABAA receptors composed of either
a1b3 or a1b3g 2 subunits, taurine is a full or partial
agonist, respectively, while both receptor types exhibit

Figure 1 Altered paired pulse facilitation in the fragile X hippocampus Paired pulse stimulation at inter-stimulus intervals (ISI) of 100 ms
and up to 300 ms consistently yielded facilitation as determined by the increase of the second EPSP (p2) compared to the first (p1). In Fmrp1KO slices, stimulation of the hippocampal slices from Fmr1-KO resulted in a consistent depression of the second evoked response at all ISI used.
Application of taurine (10µM) resulted in a paired pulse depression of WT responses but not Fmr1-KO. Each data point represents mean ± SEM
of EPSP obtained following the paired pulse stimulation and expressed as [(p2-p1)/p1*100]. Data were obtained from 3 brains in each group and
at least 5 slices per brain.
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similar taurine sensitivities [44]. Interestingly we found
that the Fmr1-KO hippocampal slices are irresponsive
to bath application of taurine. While in the WT mice,
taurine addition resulted in a significant decrease in the
amplitude of the facilitation; in the Fmr1-KO, pair pulse
stimulation resulted in a consistent depression of the
second evoked response and addition of taurine had no
effect. Taurine is a GABAA receptor agonist and modulator [31-44]. Its application to hippocampal slices result
in activation of GABAA receptors and hyperpolarization
of GABAA receptors-expressing neurons, which comprises all principal cells of the hippocampus. This leads
to reduced threshold for neuronal firing. Thus, under
these conditions paired-pulse stimulation resulted, as
expected, in a depression of neuronal response. The
finding that slices from Fmr1-KO mice show abnormal
pair pulse response and are insensitive to taurine indicates that the inhibitory GABAergic system is compromised in these mice and that the GABA A receptors
expressed in these mice lack the binding site for taurine.
Consistent with this we showed that Fmr1-KO mice
have reduced b subunit of the GABAA receptors and
taurine could presumably bind to this subunit (L’Amoreaux and El Idrissi, 2010; this volume). Furthermore,
disrupting the gene for b3 subunit of the GABAA receptor in mice produces electroencephalographic abnormalities, seizures, learning and memory deficits, poor motor
skills on a repetitive task and hyperactivity features all
common to fragile X syndrome [45]. Beta 3 subunit
phosphorylation acts as a regulatory switch to control
cycling of GABAA receptors into and out of the plasma
membrane [45]. This may allow neurons to specifically
modify cell surface receptor insertion and/or endocytosis
rates to control the efficacy of inhibitory synaptic transmission. The finding that Fmr1-KO mice have reduced
b subunit of the GABA A receptors may explain the
abnormal response to pair pulse stimulation and the
insensitivity to taurine application.

Conclusions
Fmr1-KO mice have altered GABAergic system. Here,
we show electrophysiologically that alterations in the
GABAergic system may underlie the abnormal response
to pair pulse stimulation, the cellular analogue of shortterm plasticity. Furthermore, we showed that taurine
regulates short-term plasticity in the hippocampus.
Taurine application to slices resulted in a shift from pair
pulse facilitation to pair pulse depression in WT but not
Fmr1-KO mice presumably lacking the binding site for
taurine on GABAA receptors.
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